West Pharmaceutical Services, Inc. (WST) Stock

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is led by CEO Eric Green, employs 10,800 people, headquartered in Exton, US, publicly traded since 1980.

West Pharmaceutical Services, Inc. (WST) stock trades at $368.61 with a market capitalization of $25.94B. The stock is valued at a price-to-earnings (P/E) ratio of 46.38, price-to-book of 8.64, price-to-sales of 7.72. Over the past 52 weeks the stock has ranged between $223.83 and $386.00, and currently trades 4.5% below its 52-week high. It pays a dividend yielding 0.24%.

On profitability, West Pharmaceutical Services, Inc. generates a return on equity (ROE) of 18.51%, above the typical market average, return on capital employed of 19.98%, an operating margin of 20.07%, a net profit margin of 16.98%.

In its most recent fiscal year, West Pharmaceutical Services, Inc. reported annual revenue of $3.1B, net profit of $494.0M, revenue has compounded at 7.4% a year over the last five years, profit at 7.4% a year.

The balance sheet shows a debt-to-equity ratio of 0.10 — a conservative balance sheet with little leverage risk, a current ratio of 3.02, total assets of $4.3B, $791.0M in cash and equivalents.

WST has a beta of 1.14.